Catalyst Wire Dossier Catalyst Wire Dossier

MYXREDLIN

INSULIN HUMAN · Baxter Healthcare Corporation
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MYXREDLIN, covering 2019-06-20 to 2025-03-07. Get the full timeline:

Most recent: FDA Approved: MYXREDLIN — Supplemental Application (Baxter Healthcare Corporation)

See pricing